Novo NordiskNovo Nordisk Facebook ad: “Wegovy (semaglutide 2.4mg) is the effective weight-loss*…”
Ran for 28 days, from June 2 to June 29, 2026, the last day Crush saw it.
Run by Novo Nordisk on Facebook. Crush is not the advertiser and does not verify its claims. See this ad in Meta's Ad Library(opens in a new tab)
Want an ad like this for your product?
Crush makes new ad images for your product from this ad: your logo, your product photo, your offer.
Trials from $19.95 USD, then $79.95 USD a month. Cancel anytime.
About this ad
- Meta Ad Library ID
- 1418797180291244
- Platforms
- Facebook and Instagram
- Relaunches
- 1
Ad text
Wegovy® (semaglutide 2.4mg) is the effective weight-loss* medication that also protects heart health.† It is a prescription medicine available in New Zealand. Ask your doctor if Wegovy® is right for you. *When used alongside healthy changes to your diet and physical activity. †Reduces the risk of serious heart events in people with established heart disease and a BMI ≥27 kg/m², without diabetes, in addition to standard of care heart disease therapy.
Where the ad sends people
wegovynow.co.nz
Novo Nordisk
Learn more: wegovynow.co.nz(opens in a new tab)
